Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-003924
Filing Date
2020-01-17
Accepted
2020-01-17 16:03:58
Documents
2
Period of Report
2020-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1586
2 POA DOCUMENT poa.txt EX-24.3_889273 3026
  Complete submission text file 0001209191-20-003924.txt   6085
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
Ling Geoffrey M.D. (Reporting) CIK: 0001800097 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 20533582